Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer

Lung cancer is the leading cause of cancer death in men and women. Lung adenocarcinoma (LUAD), represents approximately 40% of all lung cancer cases. Advances in recent years, such as the identification of oncogenes and the use of immunotherapies, have changed the treatment of LUAD. Yet survival rat...

Full description

Saved in:
Bibliographic Details
Published in:Front Immunol
Main Authors: Kleczko, Emily K., Kwak, Jeff W., Schenk, Erin L., Nemenoff, Raphael A.
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2019
Subjects:
Immunology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6522855/
https://ncbi.nlm.nih.gov/pubmed/31134065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.00954
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items